HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Clinical significance of anti-Ro antibodies in rheumatoid arthritis.

Abstract
The objective of our study was to determine the frequency of anti-Ro antibodies in patients with rheumatoid arthritis (RA), their clinical significance and possible serologic and genetic associations. Consecutive patients with RA (ACR '87) were studied. Other connective tissues diseases were excluded. Demographic characteristics, extra articular manifestations, and treatment were reviewed. Presence of leukopenia, thrombocytopenia, hypergammaglobulinemia, hypocomplementemia, and cryoglobulinemia were consigned. Rheumatoid factor (RF), antinuclear antibodies (ANAs), anti-Ro, and anti-La were determined by ELISA in all patients; and HLA-DR was determined by PCR and oligotyping. X-rays of the hands and feet were evaluated by Larsen's score. The study included 106 patients, 94 women and 12 men; mean age was 50.3 +/- 11.4 years, mean disease duration was 11.2 +/- 6.8 years. Main extra articular manifestations were subcutaneous nodules, xerophthalmia, and xerostomia; 75.5% of the patients were RF+. Anti-Ro antibodies were detected in 12.2% of the patients. When positive and negative anti-Ro patients were compared, no significant difference in any studied variable was observed. According to our results, anti-Ro antibodies lack clinical relevance in patients with RA.
AuthorsEmilce Schneeberger, Gustavo Citera, Monica Heredia, José Maldonado Cocco
JournalClinical rheumatology (Clin Rheumatol) Vol. 27 Issue 4 Pg. 517-9 (Apr 2008) ISSN: 0770-3198 [Print] Germany
PMID18183345 (Publication Type: Journal Article)
Chemical References
  • Antibodies, Anti-Idiotypic
  • Antibodies, Antinuclear
  • SS-A antibodies
Topics
  • Adult
  • Antibodies, Anti-Idiotypic (blood)
  • Antibodies, Antinuclear (blood)
  • Arthritis, Rheumatoid (blood, immunology)
  • Cohort Studies
  • Cross-Sectional Studies
  • Female
  • Humans
  • Male
  • Middle Aged
  • Severity of Illness Index

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: